Advanced Understanding of Staphylococcus Aureus Infections in Europe - Surgical Site Infections

NCT02935244 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5004

Last updated 2021-05-03

No results posted yet for this study

Summary

ASPIRE-SSI is a prospective, observational, multicentre cohort study among adult surgical patients, which aims to determine the incidence of healthcare-associated S. aureus infections, particularly S. aureus surgical site infections (SSIs), across Europe and to assess the most important risk factors for this type of infection.

Conditions

  • Staphylococcus Aureus
  • Surgical Wound Infection

Sponsors & Collaborators

  • MedImmune LLC

    collaborator INDUSTRY
  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Jan AJW Kluytmans, MD PhD · UMC Utrecht

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-11-30
Completion
2020-01-31

Countries

  • Belgium
  • Czechia
  • Estonia
  • France
  • Italy
  • Netherlands
  • Romania
  • Serbia
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02935244 on ClinicalTrials.gov